# Hydromorphone Versus Prochlorperazine + Diphenhydramine for Acute Migraine

> **NCT02389829** · PHASE4 · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 127 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Hydromorphone
- **DRUG:** Prochlorperazine
- **DRUG:** Diphenhydramine

## Key facts

- **NCT ID:** NCT02389829
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2016-06
- **Final completion:** 2016-10
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2018-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02389829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02389829, "Hydromorphone Versus Prochlorperazine + Diphenhydramine for Acute Migraine". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02389829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*